Literature DB >> 24476526

Adult T-cell leukemia/lymphoma.

Sohail Qayyum1, John K Choi.   

Abstract

Adult T-cell leukemia/lymphoma is a rare mature CD4(+) T-cell neoplasm caused by the retrovirus human T-lymphotrophic virus type 1. At present there are approximately 20 million people infected globally with this virus, and most of these individuals belong to the endemic areas in southern Japan, Africa, the Caribbean basin, and Latin America. In the United States, it is usually seen in immigrants from these endemic regions. Adult T-cell leukemia/lymphoma predominantly affects the adult population and is rare in children. Adult T-cell leukemia/lymphoma has 4 subtypes: acute, lymphomatous, chronic, and smoldering. Clinically, the first 2 variants are classified as aggressive, and the latter two are classified as indolent. Given the rare occurrence and diagnostic challenges associated with adult T-cell leukemia/lymphoma, this review will highlight its salient features to aid in recognition of this entity and perform a comprehensive diagnostic workup.

Entities:  

Mesh:

Year:  2014        PMID: 24476526     DOI: 10.5858/arpa.2012-0379-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

Review 1.  Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.

Authors:  Brian D Adkins; Juan C Ramos; Meghan Bliss-Moreau; Alejandro A Gru
Journal:  Semin Diagn Pathol       Date:  2019-12-20       Impact factor: 3.464

2.  HTLV-1-Associated Lymphoma Presented as Massive Lymphadenopathy.

Authors:  Pei Ting Chen; David Onukogu; Gregory Gotlieb; Rashid Chaudhry; Vijay Jaswani; Karan Josan; Cheema Akhtar; Jen Chin Wang
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

3.  Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning.

Authors:  Mohadeseh Zarei Ghobadi; Rahman Emamzadeh; Elaheh Afsaneh
Journal:  BMC Cancer       Date:  2022-04-21       Impact factor: 4.638

4.  Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.

Authors:  Xiao-Wu Chen; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-06-08       Impact factor: 4.162

5.  Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcoma.

Authors:  Marta Canuti; Cathy V Williams; Sashi R Gadi; Maarten F Jebbink; Bas B Oude Munnink; Seyed Mohammad Jazaeri Farsani; John M Cullen; Lia van der Hoek
Journal:  Front Microbiol       Date:  2014-12-01       Impact factor: 5.640

6.  Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone.

Authors:  Nicole A Kohart; Said M Elshafae; Wachirapan Supsahvad; Aylin Alasonyalilar-Demirer; Amanda R Panfil; Jingyu Xiang; Wessel P Dirksen; Deborah J Veis; Patrick L Green; Katherine N Weilbaecher; Thomas J Rosol
Journal:  J Bone Oncol       Date:  2019-08-20       Impact factor: 4.072

Review 7.  Autophagy in Human T-Cell Leukemia Virus Type 1 (HTLV-1) Induced Leukemia.

Authors:  Nicolás Ducasa; Daniel Grasso; Paula Benencio; Daniela L Papademetrio; Mirna Biglione; Fatah Kashanchi; Carolina Berini; Maria Noé Garcia
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

8.  Combination of auraptene and arsenic trioxide induces apoptosis and cellular accumulation in the subG1 phase in adult T-cell leukemia cells.

Authors:  Mohaddeseh Kazemi; Hamideh Kouhpeikar; Zahra Delbari; Faeze Khodadadi; Sina Gerayli; Mehrdad Iranshahi; Arman Mosavat; Fatemeh Behnam Rassouli; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2021-12       Impact factor: 2.699

9.  Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin.

Authors:  Ramin Bagheri; Fatemeh B Rassouli; Hamid Gholamhosseinian; Keyhan Ebrahimi; Shakiba Mahdavi; Sajad Goudarzi; Mehrdad Iranshahi; Houshang Rafatpanah; Mohammad Reza Keramati
Journal:  Dose Response       Date:  2022-09-21       Impact factor: 2.623

Review 10.  A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

Authors:  Olivier Hermine; Juan Carlos Ramos; Kensei Tobinai
Journal:  Adv Ther       Date:  2018-02-06       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.